Disclosure of Adverse Clinical Trial Results—Should Legal Immunity Be Granted to Drug Companies?

American Journal of Bioethics 9 (8):45-47 (2009)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1080/15265160902939933

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 101,297

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The Duty to Disclose Adverse Clinical Trial Results.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):24-32.
Disclosing Clinical Trial Results: Publicity, Significance and Independence.S. Matthew Liao, Mark Sheehan & Steve Clarke - 2009 - American Journal of Bioethics 9 (8):3-5.
Respecting Participant Autonomy and the Disclosure of Clinical Trial Results.Justin Oakley - 2009 - American Journal of Bioethics 9 (8):38-38.
The Duty to Disclose (Even More) Adverse Clinical Trial Results.Nicole Hassoun - 2009 - American Journal of Bioethics 9 (8):33-34.
Enhancing Informed Consent in Clinical Trials and Exploring Resistances to Disclosing Adverse Clinical Trial Results.John D. Banja & Boadie Dunlop - 2009 - American Journal of Bioethics 9 (8):39-41.
Improving Subject Recruitment By Maintaining Truly Informed Consent: A Practical Benefit of Disclosing Adverse Clinical Trial Results.Kavita R. Shah & Frances R. Batzer - 2009 - American Journal of Bioethics 9 (8):36-37.
Toward a Jurisprudence of Drug Regulation.Matthew Herder - 2014 - Journal of Law, Medicine and Ethics 42 (2):244-262.
Evaluation of drug toxicity in clinical trials.Jacek Spławiński, Jerzy Kuźniar, Krzysztof Filipiak & Waldemar Zieliński - 2006 - Science and Engineering Ethics 12 (1):139-145.
Subjects' views of obligations to ensure post-trial access to drugs, care and information: qualitative results from the Experiences of Participants in Clinical Trials (EPIC) study.N. Sofaer, C. Thiessen, S. D. Goold, J. Ballou, K. A. Getz, G. Koski, R. A. Krueger & J. S. Weissman - 2009 - Journal of Medical Ethics 35 (3):183-188.
Informed Consent and the Disclosure of Clinical Results to Research Participants.Effy Vayena, Samia A. Hurst, Celine Moret & Alessandro Blasimme - 2017 - American Journal of Bioethics 17 (7):58-60.

Analytics

Added to PP
2010-09-14

Downloads
35 (#651,090)

6 months
9 (#502,853)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

Add more citations

References found in this work

A plea for pragmatism in clinical research ethics.David H. Brendel & Franklin G. Miller - 2008 - American Journal of Bioethics 8 (4):24 – 31.
Dark Remedy: The Impact of Thalidomide and Its Revival as a Vital Medicine.[author unknown] - 2002 - Journal of the History of Biology 35 (2):387-389.

Add more references